Werbung
Werbung
ANIP
ANI Pharmaceuticals, Inc.
76.24
USDGesponsert
-4.80
-5.92%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
76.94
+0.70
+0.92%
ANIP Ergebnisberichte
Positives Überraschungsverhältnis
ANIP übertreffen die 26 der letzten 40Schätzungen.
65%
Nächster Bericht
Datum des nächsten Berichts
26. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$237.82M
/$2.07
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+4.39%
/+1.47%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+24.79%
/+26.99%
ANI Pharmaceuticals, Inc. earnings per share and revenue
On 07. Nov. 2025, ANIP reported earnings of 2.04 USD per share (EPS) for Q3 25, beating the estimate of 1.78 USD, resulting in a 14.04% surprise. Revenue reached 227.81 million, compared to an expected 215.26 million, with a 5.83% difference. The market reacted with a +0.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of 2.07 USD, with revenue projected to reach 237.82 million USD, implying an increase of 1.47% EPS, and increase of 4.39% in Revenue from the last quarter.
FAQ
What were ANI Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ANI Pharmaceuticals, Inc. reported EPS of $2.04, beating estimates by 14.04%, and revenue of $227.81M, 5.83% above expectations.
How did the market react to ANI Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 0.22%, changed from $90.23 before the earnings release to $90.43 the day after.
When is ANI Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 26. Feb. 2026.
What are the forecasts for ANI Pharmaceuticals, Inc.'s next earnings report?
Based on 10
analysts, ANI Pharmaceuticals, Inc. is expected to report EPS of $2.07 and revenue of $237.82M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung